| CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery M Fransson, E Piras, J Burman, B Nilsson, M Essand, BF Lu, RA Harris, ... Journal of neuroinflammation 9, 1-12, 2012 | 347 | 2012 |
| A phase I/IIa trial using CD19-targeted third-generation CAR T cells for lymphoma and leukemia G Enblad, H Karlsson, G Gammelgård, J Wenthe, T Lövgren, RM Amini, ... Clinical Cancer Research 24 (24), 6185-6194, 2018 | 254 | 2018 |
| Age-related somatic structural changes in the nuclear genome of human blood cells LA Forsberg, C Rasi, HR Razzaghian, G Pakalapati, L Waite, ... The American Journal of Human Genetics 90 (2), 217-228, 2012 | 242 | 2012 |
| Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis G Vasmatzis, M Essand, U Brinkmann, B Lee, I Pastan Proceedings of the National Academy of Sciences 95 (1), 300-304, 1998 | 215 | 1998 |
| Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas J Leja, A Essaghir, M Essand, K Wester, TH Tötterman, R Lloyd, ... Modern pathology 22 (2), 261-272, 2009 | 183 | 2009 |
| Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer J Ma, M Ramachandran, C Jin, C Quijano-Rubio, M Martikainen, D Yu, ... Cell death & disease 11 (1), 48, 2020 | 155 | 2020 |
| Use of macrophages to target therapeutic adenovirus to human prostate tumors M Muthana, A Giannoudis, SD Scott, HY Fang, SB Coffelt, FJ Morrow, ... Cancer research 71 (5), 1805-1815, 2011 | 151 | 2011 |
| Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain J Rostami, G Fotaki, J Sirois, R Mzezewa, J Bergström, M Essand, L Healy, ... Journal of Neuroinflammation 17, 1-18, 2020 | 149 | 2020 |
| Virus-based immunotherapy of glioblastoma M Martikainen, M Essand Cancers 11 (2), 186, 2019 | 138 | 2019 |
| PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus U Brinkmann, G Vasmatzis, B Lee, N Yerushalmi, M Essand, I Pastan Proceedings of the National Academy of Sciences 95 (18), 10757-10762, 1998 | 138 | 1998 |
| CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis R Lugano, K Vemuri, D Yu, M Bergqvist, A Smits, M Essand, S Johansson, ... The Journal of clinical investigation 128 (8), 3280-3297, 2018 | 118 | 2018 |
| Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor microenvironment A Loskog, H Dzojic, S Vikman, C Ninalga, M Essand, O Korsgren, ... The Journal of Immunology 172 (11), 7200-7205, 2004 | 113 | 2004 |
| Macrophage delivery of an oncolytic virus abolishes tumor regrowth and metastasis after chemotherapy or irradiation M Muthana, S Rodrigues, YY Chen, A Welford, R Hughes, S Tazzyman, ... Cancer research 73 (2), 490-495, 2013 | 103 | 2013 |
| TARP: A nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor γ chain locus CD Wolfgang, M Essand, JJ Vincent, B Lee, I Pastan Proceedings of the National Academy of Sciences 97 (17), 9437-9442, 2000 | 99 | 2000 |
| Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer V Hillerdal, M Essand BioDrugs 29, 75-89, 2015 | 95 | 2015 |
| CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours B Kruse, AC Buzzai, N Shridhar, AD Braun, S Gellert, K Knauth, J Pozniak, ... Nature 618 (7967), 1033-1040, 2023 | 91 | 2023 |
| Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma L van Hooren, A Vaccaro, M Ramachandran, K Vazaios, S Libard, ... Nature Communications 12 (1), 4127, 2021 | 91 | 2021 |
| Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice V Hillerdal, M Ramachandran, J Leja, M Essand BMC cancer 14, 1-9, 2014 | 90 | 2014 |
| Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy SCH Karlsson, AC Lindqvist, M Fransson, G Paul-Wetterberg, B Nilsson, ... Cancer gene therapy 20 (7), 386-393, 2013 | 80 | 2013 |
| High expression of a specific T-cell receptor γ transcript in epithelial cells of the prostate M Essand, G Vasmatzis, U Brinkmann, P Duray, B Lee, I Pastan Proceedings of the National Academy of Sciences 96 (16), 9287-9292, 1999 | 78 | 1999 |
